AptarGroup Inc (ATR, Financial), a leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing, and active material science solutions, has reported an insider sale according to a recent SEC Filing. Gael Touya, the Segment President of AptarGroup Inc, sold 3,300 shares of the company on September 9, 2024. After this transaction, the insider owns 32,165 shares of the company.
The shares were sold at a price of $151.62, valuing the transaction at approximately $500,346. This sale follows a pattern observed over the past year, where Gael Touya has sold a total of 6,800 shares and has not purchased any shares.
Looking at the broader insider transaction trend for AptarGroup Inc, there have been no insider purchases but 18 insider sales over the past year. This could be indicative of sentiment among the insiders about the stock’s valuation and future prospects.
The current market cap of AptarGroup Inc stands at $10.07 billion. The stock’s price-earnings ratio is 31.87, which is above both the industry median of 26.32 and the company’s historical median. This higher price-earnings ratio suggests a premium valuation compared to its peers.
According to the GF Value, the intrinsic value of AptarGroup Inc’s stock is estimated at $130.72, which makes the current price of $151.62 appear modestly overvalued with a price-to-GF-Value ratio of 1.16.
The GF Value is calculated considering historical trading multiples like the price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from analysts.
This recent insider sale by Gael Touya might provide investors with interesting insights into the current valuation and future expectations for AptarGroup Inc.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
